NYU Langone’s Division of Pulmonary, Critical Care, and Sleep Medicine conducts multidisciplinary research in sarcoidosis to address the growing number of patients with this condition.
Rany Condos, MD, Doreen J. Addrizzo-Harris, MD, Kerry Hena, MD, and Odai Sinokrot, MD, lead our sarcoidosis research team, which is an integral part of NYU Langone’ Sarcoidosis Program. Our clinician–scientists, which include pulmonologists, interventional pulmonologists, cardiologists, rheumatologists, and radiologists, as well as specialists in ophthalmology, dermatology, nephrology, and gastroenterology, are committed to better understanding the disease and improving the quality of life in sarcoidosis patients.
Our research in sarcoidosis focuses on expanding and developing further information about the treatment and etiology of sarcoidosis for both the patient population and healthcare professionals. We also conduct multicenter clinical trials and offer the latest available sarcoidosis therapies.
Cleven KL … Prezant DJ. Genetic variants associated with FDNY WTC-related sarcoidosis. Int J Environ Res Public Health. 2019. DOI.
Hena KM … Reibman J. Clinical evaluation of sarcoidosis in community members with World Trade Center dust exposure. Int J Environ Res Public Health. 2019. DOI.
Hena KM … Prezant DJ. Clinical course of sarcoidosis in World Trade Center-exposed firefighters. Chest. 2018. DOI.